Article

Range of Effective Corticosteroid Doses for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review

---

This study aimed to determine the range of mean cumulative corticosteroid doses that could effectively palliate dyspnea in opioid-treated patients with terminal cancer and to investigate the demographic or biochemical factors predictive of corticosteroid responsiveness. To this end, responders and nonresponderswere comparedwith regard to corticosteroid dose and whether they had initiated opioid use before or concomitantly with corticosteroid use. A logistic regression analysis was conducted to assess the impacts of demographic and biochemical factors on corticosteroid effectiveness. The final sample comprised 20 patients who satisfied the selection criteria. The responders accounted for 70% of the total sample (n = 14) and experienced the strongest effect with regard to dyspnea palliation at a mean cumulative dose equivalent to 64.4 mg prednisolone. However, no factors predictive of response were identified. In summary, this retrospective study identified effective corticosteroid doses for dyspnea alleviation in terminal cancer patients. Although our study sample was limited in size, the results support further prospective research.

---

Ketersediaan

Informasi Detail

Judul Seri

Journal of Pain & Palliative Care Pharmacotherapy

No. Panggil

ATC LO MAE r

Penerbit

Japan : Taylor and Francis., 2017

Deskripsi Fisik

7 p.

Bahasa

English

ISBN/ISSN

1536-0539

Klasifikasi

LO

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

online resource

Edisi

2017

Subjek

Terminal cancer patients
cancer
corticosteroids
dyspnea
dose-response relationship
drug
inpatient terminal care

Info Detail Spesifik

-

Pernyataan Tanggungjawab

Tsuyoshi Maeda

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar